Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiration, Artificial | 54 | 2023 | 334 | 9.890 |
Why?
|
Critical Illness | 47 | 2023 | 294 | 8.290 |
Why?
|
Intensive Care Units | 48 | 2023 | 373 | 7.600 |
Why?
|
Hypnotics and Sedatives | 26 | 2022 | 125 | 5.320 |
Why?
|
Conscious Sedation | 21 | 2018 | 64 | 5.040 |
Why?
|
Early Ambulation | 10 | 2023 | 25 | 4.290 |
Why?
|
Respiratory Insufficiency | 13 | 2023 | 150 | 3.890 |
Why?
|
Noninvasive Ventilation | 10 | 2022 | 24 | 3.840 |
Why?
|
Delirium | 18 | 2018 | 66 | 3.810 |
Why?
|
Critical Care | 27 | 2023 | 370 | 2.990 |
Why?
|
Muscle Weakness | 7 | 2018 | 61 | 2.400 |
Why?
|
Sepsis | 10 | 2020 | 306 | 2.250 |
Why?
|
Ventilator Weaning | 9 | 2017 | 24 | 1.940 |
Why?
|
Physical Therapy Modalities | 8 | 2021 | 84 | 1.830 |
Why?
|
Propofol | 9 | 2014 | 89 | 1.670 |
Why?
|
Analgesia | 7 | 2020 | 57 | 1.590 |
Why?
|
Shock, Septic | 5 | 2023 | 102 | 1.320 |
Why?
|
Humans | 129 | 2023 | 86643 | 1.290 |
Why?
|
Pain | 8 | 2018 | 391 | 1.270 |
Why?
|
Masks | 3 | 2018 | 29 | 1.160 |
Why?
|
Vasoconstrictor Agents | 3 | 2018 | 53 | 1.140 |
Why?
|
Length of Stay | 18 | 2022 | 702 | 1.110 |
Why?
|
Intubation | 2 | 2017 | 21 | 1.100 |
Why?
|
Head Protective Devices | 4 | 2023 | 20 | 1.100 |
Why?
|
Occupational Therapy | 4 | 2018 | 16 | 1.020 |
Why?
|
Benzodiazepines | 5 | 2016 | 65 | 0.970 |
Why?
|
Polyneuropathies | 2 | 2014 | 27 | 0.960 |
Why?
|
Fentanyl | 2 | 2014 | 65 | 0.960 |
Why?
|
Intubation, Intratracheal | 4 | 2021 | 144 | 0.940 |
Why?
|
Deep Sedation | 4 | 2018 | 15 | 0.890 |
Why?
|
Male | 59 | 2023 | 40965 | 0.880 |
Why?
|
Aged | 41 | 2021 | 18415 | 0.880 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2023 | 53 | 0.880 |
Why?
|
Middle Aged | 52 | 2021 | 25028 | 0.880 |
Why?
|
Hematologic Neoplasms | 3 | 2016 | 329 | 0.850 |
Why?
|
Respiratory Dead Space | 1 | 2021 | 4 | 0.830 |
Why?
|
Female | 59 | 2023 | 44532 | 0.820 |
Why?
|
Midazolam | 4 | 2009 | 48 | 0.820 |
Why?
|
Airway Extubation | 3 | 2018 | 13 | 0.800 |
Why?
|
Neuromuscular Blocking Agents | 3 | 2023 | 29 | 0.790 |
Why?
|
Immunocompromised Host | 3 | 2018 | 140 | 0.790 |
Why?
|
Cognitive Dysfunction | 1 | 2023 | 132 | 0.760 |
Why?
|
Carbon Dioxide | 1 | 2021 | 188 | 0.760 |
Why?
|
Adult | 47 | 2023 | 25648 | 0.760 |
Why?
|
Statistics as Topic | 1 | 2021 | 238 | 0.760 |
Why?
|
Dexmedetomidine | 2 | 2010 | 11 | 0.710 |
Why?
|
Psychomotor Agitation | 5 | 2018 | 26 | 0.660 |
Why?
|
Laryngeal Masks | 1 | 2018 | 12 | 0.650 |
Why?
|
Analgesics | 2 | 2009 | 119 | 0.640 |
Why?
|
Analgesics, Opioid | 4 | 2012 | 413 | 0.640 |
Why?
|
Lidocaine | 1 | 2018 | 63 | 0.640 |
Why?
|
Immobilization | 2 | 2014 | 22 | 0.620 |
Why?
|
Anesthetics, Local | 1 | 2018 | 76 | 0.620 |
Why?
|
Practice Guidelines as Topic | 4 | 2013 | 1036 | 0.610 |
Why?
|
Lung Injury | 1 | 2017 | 47 | 0.600 |
Why?
|
Bacteremia | 4 | 2020 | 99 | 0.590 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2022 | 60 | 0.580 |
Why?
|
Positive-Pressure Respiration | 6 | 2021 | 41 | 0.570 |
Why?
|
Organ Dysfunction Scores | 1 | 2016 | 27 | 0.570 |
Why?
|
Staphylococcal Infections | 3 | 2020 | 255 | 0.570 |
Why?
|
Survivors | 3 | 2012 | 226 | 0.560 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2016 | 24 | 0.550 |
Why?
|
Pain Management | 5 | 2020 | 127 | 0.550 |
Why?
|
Lorazepam | 3 | 2010 | 16 | 0.530 |
Why?
|
Catheterization, Central Venous | 3 | 2015 | 116 | 0.510 |
Why?
|
Vasopressins | 2 | 2013 | 49 | 0.500 |
Why?
|
Ventilators, Mechanical | 2 | 2013 | 33 | 0.490 |
Why?
|
Logistic Models | 7 | 2021 | 1186 | 0.490 |
Why?
|
Hyperglycemia | 2 | 2018 | 176 | 0.490 |
Why?
|
Acute Lung Injury | 1 | 2014 | 60 | 0.480 |
Why?
|
Hemorrhage | 1 | 2016 | 268 | 0.480 |
Why?
|
Immune System Diseases | 1 | 2014 | 26 | 0.470 |
Why?
|
Thoracic Diseases | 2 | 2007 | 25 | 0.470 |
Why?
|
Humidity | 1 | 2013 | 89 | 0.470 |
Why?
|
ROC Curve | 5 | 2021 | 752 | 0.440 |
Why?
|
Norepinephrine | 1 | 2013 | 167 | 0.440 |
Why?
|
Treatment Outcome | 10 | 2023 | 7993 | 0.430 |
Why?
|
Physical Examination | 2 | 2006 | 149 | 0.430 |
Why?
|
Pain Measurement | 5 | 2018 | 321 | 0.430 |
Why?
|
Exercise | 2 | 2014 | 315 | 0.420 |
Why?
|
Staphylococcus aureus | 2 | 2018 | 263 | 0.420 |
Why?
|
Long-Term Care | 1 | 2012 | 61 | 0.410 |
Why?
|
Disabled Persons | 1 | 2012 | 67 | 0.400 |
Why?
|
Biomedical Research | 2 | 2014 | 376 | 0.400 |
Why?
|
Tracheotomy | 1 | 2011 | 18 | 0.400 |
Why?
|
Health Services Research | 1 | 2012 | 136 | 0.390 |
Why?
|
Time Factors | 11 | 2021 | 5210 | 0.390 |
Why?
|
Continuity of Patient Care | 1 | 2012 | 169 | 0.390 |
Why?
|
Retrospective Studies | 15 | 2021 | 8489 | 0.380 |
Why?
|
Anxiety | 3 | 2013 | 287 | 0.370 |
Why?
|
Risk Factors | 10 | 2016 | 5417 | 0.360 |
Why?
|
Neuromuscular Diseases | 1 | 2009 | 30 | 0.350 |
Why?
|
Recovery of Function | 1 | 2011 | 272 | 0.350 |
Why?
|
Quality Improvement | 1 | 2013 | 428 | 0.350 |
Why?
|
GABA Modulators | 1 | 2009 | 9 | 0.340 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2009 | 34 | 0.340 |
Why?
|
Pneumonia | 3 | 2022 | 179 | 0.340 |
Why?
|
Exercise Therapy | 1 | 2009 | 80 | 0.330 |
Why?
|
Attitude of Health Personnel | 2 | 2013 | 636 | 0.330 |
Why?
|
Neck | 1 | 2009 | 100 | 0.330 |
Why?
|
Wakefulness | 4 | 2010 | 134 | 0.320 |
Why?
|
Societies, Medical | 1 | 2012 | 572 | 0.320 |
Why?
|
Quality of Life | 4 | 2023 | 1585 | 0.310 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 56 | 0.310 |
Why?
|
Pulmonary Edema | 1 | 2008 | 50 | 0.310 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 859 | 0.310 |
Why?
|
Hospital Mortality | 5 | 2018 | 349 | 0.300 |
Why?
|
Lymphatic Diseases | 1 | 2007 | 37 | 0.300 |
Why?
|
Etomidate | 1 | 2007 | 11 | 0.300 |
Why?
|
Sleep Wake Disorders | 2 | 2018 | 115 | 0.300 |
Why?
|
Prognosis | 6 | 2016 | 3679 | 0.300 |
Why?
|
Adrenal Glands | 1 | 2007 | 76 | 0.290 |
Why?
|
Central Venous Pressure | 1 | 2006 | 26 | 0.290 |
Why?
|
Anesthetics, Intravenous | 1 | 2007 | 41 | 0.290 |
Why?
|
Thoracotomy | 1 | 2007 | 58 | 0.290 |
Why?
|
Muscle Strength | 2 | 2018 | 31 | 0.290 |
Why?
|
Respiratory Paralysis | 1 | 2006 | 8 | 0.290 |
Why?
|
Jugular Veins | 1 | 2006 | 69 | 0.290 |
Why?
|
Biopsy, Needle | 1 | 2007 | 235 | 0.280 |
Why?
|
Hypercapnia | 1 | 2006 | 43 | 0.280 |
Why?
|
Endosonography | 1 | 2007 | 96 | 0.280 |
Why?
|
Spinal Cord Neoplasms | 1 | 2006 | 48 | 0.280 |
Why?
|
Cardiac Surgical Procedures | 1 | 2011 | 462 | 0.280 |
Why?
|
APACHE | 4 | 2016 | 21 | 0.280 |
Why?
|
Patient-Centered Care | 1 | 2008 | 203 | 0.270 |
Why?
|
Myeloproliferative Disorders | 1 | 2007 | 110 | 0.270 |
Why?
|
Pulmonary Artery | 1 | 2007 | 306 | 0.270 |
Why?
|
Prospective Studies | 9 | 2023 | 4213 | 0.270 |
Why?
|
Myocardial Ischemia | 1 | 2007 | 162 | 0.270 |
Why?
|
Chicago | 4 | 2021 | 1379 | 0.260 |
Why?
|
United States | 10 | 2023 | 6672 | 0.260 |
Why?
|
Oxygen | 4 | 2022 | 726 | 0.250 |
Why?
|
Cohort Studies | 4 | 2021 | 2767 | 0.250 |
Why?
|
Algorithms | 5 | 2016 | 1830 | 0.240 |
Why?
|
Single-Blind Method | 3 | 2014 | 153 | 0.240 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2003 | 48 | 0.230 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 346 | 0.230 |
Why?
|
Infusions, Intravenous | 5 | 2012 | 429 | 0.230 |
Why?
|
Immunity | 2 | 2022 | 136 | 0.230 |
Why?
|
Lymph Nodes | 1 | 2007 | 533 | 0.230 |
Why?
|
Follow-Up Studies | 4 | 2014 | 3640 | 0.220 |
Why?
|
Terminal Care | 1 | 2004 | 130 | 0.220 |
Why?
|
Diaphragm | 1 | 2022 | 50 | 0.220 |
Why?
|
Multiple Myeloma | 1 | 2006 | 307 | 0.220 |
Why?
|
Respiratory Mechanics | 1 | 2023 | 102 | 0.220 |
Why?
|
Helium | 1 | 2002 | 10 | 0.220 |
Why?
|
Blood Glucose | 2 | 2018 | 873 | 0.220 |
Why?
|
Albuterol | 1 | 2002 | 35 | 0.210 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 350 | 0.210 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2003 | 96 | 0.210 |
Why?
|
Restraint, Physical | 2 | 2018 | 27 | 0.210 |
Why?
|
Narcotics | 1 | 2002 | 69 | 0.210 |
Why?
|
Validation Studies as Topic | 1 | 2021 | 16 | 0.210 |
Why?
|
Drug Therapy, Combination | 3 | 2009 | 894 | 0.200 |
Why?
|
Oxygen Consumption | 2 | 1999 | 239 | 0.200 |
Why?
|
Statistics, Nonparametric | 4 | 2018 | 307 | 0.200 |
Why?
|
Adolescent | 3 | 2023 | 8981 | 0.190 |
Why?
|
Survival Analysis | 2 | 2014 | 1538 | 0.190 |
Why?
|
Pandemics | 3 | 2023 | 740 | 0.190 |
Why?
|
Body Temperature | 1 | 2020 | 124 | 0.190 |
Why?
|
Symptom Assessment | 1 | 2020 | 65 | 0.190 |
Why?
|
Justicia | 1 | 2020 | 1 | 0.190 |
Why?
|
Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
Mental Disorders | 1 | 2003 | 371 | 0.180 |
Why?
|
Activities of Daily Living | 2 | 2013 | 204 | 0.180 |
Why?
|
Work of Breathing | 1 | 1999 | 5 | 0.180 |
Why?
|
Endocardium | 1 | 2000 | 76 | 0.180 |
Why?
|
Bed Rest | 2 | 2009 | 5 | 0.180 |
Why?
|
Heart Arrest | 2 | 2014 | 265 | 0.180 |
Why?
|
Plant Leaves | 1 | 2020 | 72 | 0.180 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 429 | 0.180 |
Why?
|
Oxyhemoglobins | 1 | 1999 | 31 | 0.180 |
Why?
|
Heart Neoplasms | 1 | 2000 | 62 | 0.180 |
Why?
|
Antibodies, Viral | 1 | 2020 | 293 | 0.170 |
Why?
|
Hematopoiesis | 1 | 2020 | 163 | 0.170 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2000 | 138 | 0.170 |
Why?
|
Oximetry | 1 | 1999 | 84 | 0.170 |
Why?
|
Laryngeal Edema | 1 | 2018 | 7 | 0.170 |
Why?
|
Hospitals, Low-Volume | 1 | 2018 | 18 | 0.170 |
Why?
|
Aged, 80 and over | 6 | 2018 | 6509 | 0.160 |
Why?
|
Liver Diseases | 1 | 2000 | 238 | 0.160 |
Why?
|
Pain Perception | 1 | 2018 | 18 | 0.160 |
Why?
|
Hospitals, High-Volume | 1 | 2018 | 35 | 0.160 |
Why?
|
Patients' Rooms | 2 | 2014 | 14 | 0.160 |
Why?
|
Enteral Nutrition | 1 | 2018 | 102 | 0.160 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 117 | 0.160 |
Why?
|
Sarcoma | 1 | 2000 | 215 | 0.160 |
Why?
|
Clinical Protocols | 4 | 2017 | 156 | 0.160 |
Why?
|
Plant Extracts | 1 | 2020 | 244 | 0.160 |
Why?
|
Overweight | 1 | 2018 | 118 | 0.150 |
Why?
|
Resuscitation | 2 | 2013 | 100 | 0.150 |
Why?
|
Anemia, Sickle Cell | 1 | 1999 | 131 | 0.150 |
Why?
|
Hospital Costs | 1 | 2018 | 105 | 0.150 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 141 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
Neurologic Examination | 1 | 1997 | 118 | 0.150 |
Why?
|
Clinical Trials as Topic | 2 | 2014 | 1169 | 0.150 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 71 | 0.140 |
Why?
|
Point-of-Care Testing | 1 | 2016 | 24 | 0.140 |
Why?
|
Obesity, Morbid | 1 | 1999 | 225 | 0.140 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 20 | 0.140 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 93 | 0.140 |
Why?
|
Lung Neoplasms | 2 | 2007 | 2262 | 0.140 |
Why?
|
Capillary Permeability | 1 | 2017 | 130 | 0.140 |
Why?
|
Skin Ulcer | 1 | 2016 | 25 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2016 | 47 | 0.140 |
Why?
|
Age Factors | 3 | 2016 | 1851 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2016 | 39 | 0.140 |
Why?
|
Rheumatic Diseases | 1 | 2016 | 20 | 0.140 |
Why?
|
Equipment Design | 1 | 2016 | 406 | 0.130 |
Why?
|
Self-Injurious Behavior | 1 | 2017 | 105 | 0.130 |
Why?
|
Central Venous Catheters | 1 | 2015 | 23 | 0.130 |
Why?
|
Medicaid | 1 | 2018 | 217 | 0.130 |
Why?
|
Butyrophenones | 2 | 2006 | 5 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Physicians | 1 | 2022 | 673 | 0.130 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 435 | 0.130 |
Why?
|
Urban Population | 2 | 2014 | 213 | 0.120 |
Why?
|
Medicare | 1 | 2018 | 410 | 0.120 |
Why?
|
Patient Positioning | 1 | 2014 | 63 | 0.120 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2014 | 45 | 0.120 |
Why?
|
Asthma | 1 | 2002 | 955 | 0.120 |
Why?
|
Interactive Ventilatory Support | 1 | 2013 | 5 | 0.120 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 115 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2013 | 20 | 0.120 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2013 | 31 | 0.120 |
Why?
|
Forecasting | 1 | 2014 | 304 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2016 | 1801 | 0.120 |
Why?
|
Insulin | 2 | 2018 | 1160 | 0.110 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2012 | 4 | 0.110 |
Why?
|
Leukemic Infiltration | 1 | 2012 | 14 | 0.110 |
Why?
|
Arterial Pressure | 1 | 2013 | 38 | 0.110 |
Why?
|
Conjunctival Diseases | 1 | 2012 | 7 | 0.110 |
Why?
|
Organizational Culture | 1 | 2012 | 33 | 0.110 |
Why?
|
Erythema | 1 | 2012 | 27 | 0.110 |
Why?
|
Cytokines | 3 | 2023 | 776 | 0.110 |
Why?
|
Neoplasms | 2 | 2016 | 2898 | 0.110 |
Why?
|
Sensitivity and Specificity | 4 | 2011 | 1991 | 0.110 |
Why?
|
Injections, Intravenous | 1 | 2012 | 244 | 0.110 |
Why?
|
Professional Role | 1 | 2012 | 41 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2015 | 243 | 0.110 |
Why?
|
Young Adult | 2 | 2014 | 5976 | 0.110 |
Why?
|
Family Health | 1 | 2012 | 162 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2014 | 379 | 0.100 |
Why?
|
Early Medical Intervention | 1 | 2011 | 18 | 0.100 |
Why?
|
Insulin Resistance | 1 | 2014 | 377 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 1961 | 0.100 |
Why?
|
Obesity | 1 | 2018 | 963 | 0.100 |
Why?
|
Cost of Illness | 1 | 2012 | 150 | 0.100 |
Why?
|
Work | 1 | 2011 | 16 | 0.100 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 288 | 0.100 |
Why?
|
Research Design | 1 | 2014 | 594 | 0.100 |
Why?
|
Patient Readmission | 1 | 2014 | 329 | 0.100 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 977 | 0.090 |
Why?
|
Patient Discharge | 2 | 2011 | 300 | 0.090 |
Why?
|
Patient Care Team | 1 | 2012 | 280 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2013 | 865 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2011 | 223 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2004 | 229 | 0.090 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2009 | 24 | 0.090 |
Why?
|
Communication | 2 | 2004 | 441 | 0.090 |
Why?
|
Iowa | 1 | 2009 | 35 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 1565 | 0.090 |
Why?
|
Mobility Limitation | 1 | 2009 | 19 | 0.090 |
Why?
|
Evaluation Studies as Topic | 2 | 1999 | 274 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2009 | 136 | 0.080 |
Why?
|
Tidal Volume | 1 | 2008 | 53 | 0.080 |
Why?
|
Inhalation | 1 | 2008 | 31 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2006 | 1673 | 0.080 |
Why?
|
Decision Trees | 2 | 2008 | 63 | 0.080 |
Why?
|
Drug Tolerance | 1 | 2008 | 63 | 0.080 |
Why?
|
Practice Patterns, Physicians' | 1 | 2013 | 582 | 0.080 |
Why?
|
Thrombocythemia, Essential | 1 | 2007 | 14 | 0.080 |
Why?
|
Platelet Count | 1 | 2007 | 92 | 0.080 |
Why?
|
HIV Infections | 1 | 2016 | 772 | 0.080 |
Why?
|
Ultrasonography | 2 | 2009 | 695 | 0.080 |
Why?
|
Evidence-Based Emergency Medicine | 2 | 2016 | 2 | 0.070 |
Why?
|
Clinical Competence | 1 | 2012 | 751 | 0.070 |
Why?
|
Medical Staff | 1 | 2006 | 10 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 860 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2006 | 229 | 0.070 |
Why?
|
Signal Transduction | 1 | 2017 | 3241 | 0.070 |
Why?
|
Catheterization | 1 | 2007 | 232 | 0.070 |
Why?
|
Blood Pressure Determination | 1 | 2006 | 90 | 0.070 |
Why?
|
Equipment Failure | 1 | 2006 | 119 | 0.070 |
Why?
|
Cognition | 1 | 2010 | 570 | 0.070 |
Why?
|
Cardiac Catheterization | 1 | 2007 | 291 | 0.070 |
Why?
|
Observer Variation | 3 | 2014 | 602 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2007 | 263 | 0.070 |
Why?
|
Hydrocortisone | 1 | 2007 | 298 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2007 | 486 | 0.060 |
Why?
|
Odds Ratio | 2 | 2018 | 678 | 0.060 |
Why?
|
Lung | 1 | 2011 | 1170 | 0.060 |
Why?
|
Infusions, Parenteral | 1 | 2004 | 50 | 0.060 |
Why?
|
Barotrauma | 1 | 2004 | 5 | 0.060 |
Why?
|
Thrombosis | 1 | 2007 | 296 | 0.060 |
Why?
|
Organizational Innovation | 1 | 2004 | 41 | 0.060 |
Why?
|
Cholestasis | 1 | 2004 | 47 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2004 | 81 | 0.060 |
Why?
|
Goals | 1 | 2004 | 67 | 0.060 |
Why?
|
Psychology | 1 | 2003 | 24 | 0.060 |
Why?
|
Mental Processes | 1 | 2003 | 31 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 912 | 0.060 |
Why?
|
Time | 1 | 2003 | 77 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2004 | 118 | 0.060 |
Why?
|
Hospital Records | 1 | 2003 | 3 | 0.060 |
Why?
|
Thromboembolism | 1 | 2004 | 119 | 0.060 |
Why?
|
Proxy | 1 | 2003 | 24 | 0.060 |
Why?
|
Pharmacists | 1 | 2023 | 32 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 916 | 0.060 |
Why?
|
Paralysis | 1 | 2022 | 23 | 0.060 |
Why?
|
Status Asthmaticus | 1 | 2002 | 9 | 0.060 |
Why?
|
Prevalence | 1 | 2007 | 1239 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2004 | 220 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2022 | 61 | 0.050 |
Why?
|
Spirometry | 1 | 2002 | 66 | 0.050 |
Why?
|
Atrophy | 1 | 2022 | 117 | 0.050 |
Why?
|
District of Columbia | 1 | 2021 | 20 | 0.050 |
Why?
|
Blood Pressure | 1 | 2007 | 1143 | 0.050 |
Why?
|
Forced Expiratory Volume | 1 | 2002 | 122 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2002 | 188 | 0.050 |
Why?
|
Pseudomonas Infections | 1 | 2002 | 95 | 0.050 |
Why?
|
Sinusitis | 1 | 2004 | 210 | 0.050 |
Why?
|
Drug Combinations | 1 | 2002 | 224 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2007 | 1939 | 0.050 |
Why?
|
Nebulizers and Vaporizers | 1 | 2002 | 55 | 0.050 |
Why?
|
Emergencies | 1 | 2002 | 113 | 0.050 |
Why?
|
Delphi Technique | 1 | 2021 | 80 | 0.050 |
Why?
|
Cannula | 1 | 2021 | 47 | 0.050 |
Why?
|
Congresses as Topic | 1 | 2021 | 116 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2014 | 2705 | 0.050 |
Why?
|
Hospitalization | 2 | 2018 | 849 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
Informed Consent | 1 | 2003 | 266 | 0.050 |
Why?
|
Phytochemicals | 1 | 2020 | 5 | 0.050 |
Why?
|
Erythrocyte Indices | 1 | 2020 | 10 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 112 | 0.050 |
Why?
|
Brain | 1 | 2010 | 2216 | 0.050 |
Why?
|
Fever | 1 | 2020 | 125 | 0.050 |
Why?
|
Consensus | 1 | 2021 | 335 | 0.050 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 1999 | 18 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2020 | 162 | 0.040 |
Why?
|
Hemoglobin, Sickle | 1 | 1999 | 19 | 0.040 |
Why?
|
Hemoglobins | 1 | 2020 | 179 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2020 | 188 | 0.040 |
Why?
|
Auscultation | 1 | 1999 | 4 | 0.040 |
Why?
|
Hospitals, University | 1 | 1999 | 194 | 0.040 |
Why?
|
Morphine | 1 | 2000 | 130 | 0.040 |
Why?
|
Palpation | 1 | 1999 | 18 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2021 | 751 | 0.040 |
Why?
|
Neutropenia | 1 | 1999 | 215 | 0.040 |
Why?
|
Skin | 1 | 2002 | 554 | 0.040 |
Why?
|
Anemia | 1 | 2020 | 128 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 1999 | 286 | 0.040 |
Why?
|
Food, Formulated | 1 | 2018 | 24 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 315 | 0.040 |
Why?
|
Dietary Proteins | 1 | 2018 | 30 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 21 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2018 | 38 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2020 | 456 | 0.040 |
Why?
|
Energy Intake | 1 | 2018 | 98 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2018 | 33 | 0.040 |
Why?
|
Syndrome | 1 | 1999 | 446 | 0.040 |
Why?
|
Likelihood Functions | 1 | 1999 | 251 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2018 | 94 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2000 | 552 | 0.040 |
Why?
|
Lymphoma | 1 | 1999 | 262 | 0.040 |
Why?
|
Patient Admission | 1 | 1998 | 112 | 0.040 |
Why?
|
Th17 Cells | 1 | 2018 | 80 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2000 | 999 | 0.040 |
Why?
|
Leukemia | 1 | 1999 | 320 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 484 | 0.040 |
Why?
|
Th1 Cells | 1 | 2018 | 164 | 0.040 |
Why?
|
Th2 Cells | 1 | 2018 | 146 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2017 | 48 | 0.040 |
Why?
|
Acute Disease | 1 | 1999 | 826 | 0.040 |
Why?
|
Ambulatory Care | 1 | 1998 | 181 | 0.040 |
Why?
|
Thorax | 1 | 2017 | 75 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 73 | 0.040 |
Why?
|
Neuropeptides | 1 | 2017 | 112 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2018 | 679 | 0.040 |
Why?
|
Hypoxia | 1 | 2021 | 641 | 0.030 |
Why?
|
Body Mass Index | 1 | 1999 | 770 | 0.030 |
Why?
|
Preoperative Care | 1 | 1998 | 397 | 0.030 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2015 | 3 | 0.030 |
Why?
|
Bronchitis | 1 | 2015 | 7 | 0.030 |
Why?
|
Tracheitis | 1 | 2015 | 3 | 0.030 |
Why?
|
Euthyroid Sick Syndromes | 1 | 2015 | 11 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2000 | 469 | 0.030 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 23 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2016 | 69 | 0.030 |
Why?
|
Survival Rate | 1 | 1999 | 1863 | 0.030 |
Why?
|
Catheter-Related Infections | 1 | 2015 | 23 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 295 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2015 | 69 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2015 | 49 | 0.030 |
Why?
|
Cell Line | 1 | 2020 | 2468 | 0.030 |
Why?
|
Malnutrition | 1 | 2015 | 34 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 76 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 1998 | 455 | 0.030 |
Why?
|
Neural Conduction | 1 | 2014 | 69 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2000 | 760 | 0.030 |
Why?
|
Communication Barriers | 1 | 2014 | 29 | 0.030 |
Why?
|
Mice | 2 | 2020 | 11352 | 0.030 |
Why?
|
Electromyography | 1 | 2014 | 183 | 0.030 |
Why?
|
Clinical Decision-Making | 1 | 2016 | 257 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 1219 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 2426 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2018 | 1805 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 136 | 0.030 |
Why?
|
Psychometrics | 1 | 2014 | 327 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 1996 | 492 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 1999 | 736 | 0.030 |
Why?
|
Databases, Factual | 1 | 2016 | 814 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2000 | 1268 | 0.030 |
Why?
|
Organ Transplantation | 1 | 2016 | 265 | 0.030 |
Why?
|
Regression Analysis | 1 | 2013 | 596 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2012 | 293 | 0.030 |
Why?
|
American Heart Association | 1 | 2011 | 92 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 295 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 364 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2011 | 42 | 0.020 |
Why?
|
Incidence | 1 | 2015 | 1577 | 0.020 |
Why?
|
Animals | 3 | 2020 | 26582 | 0.020 |
Why?
|
Rats | 1 | 2017 | 3990 | 0.020 |
Why?
|
Disease Management | 1 | 2013 | 327 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 3092 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2011 | 112 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2017 | 2232 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2011 | 107 | 0.020 |
Why?
|
Linear Models | 1 | 2011 | 421 | 0.020 |
Why?
|
Electrocardiography | 1 | 2011 | 478 | 0.020 |
Why?
|
Inpatients | 1 | 2011 | 297 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 1988 | 95 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 1988 | 107 | 0.020 |
Why?
|
Safety | 1 | 2008 | 152 | 0.020 |
Why?
|
Respiration | 1 | 2008 | 262 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 454 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 2261 | 0.020 |
Why?
|
Surveys and Questionnaires | 2 | 2003 | 2501 | 0.010 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2002 | 15 | 0.010 |
Why?
|
Necrosis | 1 | 2002 | 204 | 0.010 |
Why?
|
Treatment Failure | 1 | 2002 | 285 | 0.010 |
Why?
|
Internship and Residency | 1 | 2011 | 1004 | 0.010 |
Why?
|
Illinois | 1 | 2002 | 462 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2003 | 238 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2003 | 351 | 0.010 |
Why?
|
Vegetables | 1 | 1999 | 45 | 0.010 |
Why?
|
Fruit | 1 | 1999 | 75 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 376 | 0.010 |
Why?
|
Total Quality Management | 1 | 1998 | 34 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 1999 | 429 | 0.010 |
Why?
|
Disease Progression | 1 | 1999 | 1531 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1999 | 2601 | 0.010 |
Why?
|
Leg | 1 | 1988 | 137 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1988 | 197 | 0.000 |
Why?
|
Angiography | 1 | 1988 | 208 | 0.000 |
Why?
|